Apr 24
|
Labcorp Holdings (NYSE:LH) Expands Precision Oncology Portfolio with FDA-Authorized Liquid Biopsy Tests
|
Apr 23
|
Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions
|
Apr 22
|
Labcorp (LH) Earnings Expected to Grow: Should You Buy?
|
Apr 22
|
The three-year earnings decline is not helping Labcorp Holdings' (NYSE:LH share price, as stock falls another 6.9% in past week
|
Apr 22
|
Labcorp acquires ambulatory outreach laboratory business of NMHS
|
Mar 14
|
Labcorp is Set to Acquire Select Assets of BioReference Health of OPK
|
Mar 14
|
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)
|
Mar 12
|
Labcorp to acquire certain assets of Opko Health’s BioReference Health
|
Mar 12
|
Truist remains bullish on Labcorp after ‘another nice strategic acquisition’
|
Mar 12
|
Labcorp to buy Opko unit’s cancer test assets for up to $225M
|
Mar 11
|
Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
|
Mar 10
|
Labcorp Holdings' (NYSE:LH) Strong Earnings Are Of Good Quality
|
Feb 27
|
Labcorp Holdings Full Year 2024 Earnings: EPS Misses Expectations
|
Feb 26
|
Here's Why Labcorp (LH) is a Strong Value Stock
|
Feb 25
|
Labcorp Holdings (NYSE:LH) Will Pay A Dividend Of $0.72
|
Feb 24
|
Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors
|
Feb 22
|
Here's What We Like About Labcorp Holdings' (NYSE:LH) Upcoming Dividend
|
Feb 19
|
Hims & Hers Health surges on acquisition for at-home testing
|
Feb 14
|
Labcorp Holdings' (NYSE:LH) Solid Earnings Are Supported By Other Strong Factors
|
Feb 12
|
Trickle-down effect of NIH funding battle worries healthcare analysts and medical experts
|